Procedure-Specific Discharge Documentation by Vascular Procedure Type
- Carotid endarterectomy (CEA) discharge instructions must address neurological warning signs that could indicate stroke, transient ischemic attack (TIA), or carotid artery occlusion. Patients must be instructed to return immediately or call 911 for any of the following: sudden weakness or numbness of the face, arm, or leg (particularly on one side); sudden speech difficulty or inability to understand speech; sudden vision loss in one eye; or sudden severe headache. The Society for Vascular Surgery (SVS) clinical practice guidelines for CEA recommend aspirin therapy continuation from the pre-operative period through the post-operative course. Discharge documentation must confirm that antiplatelet therapy instructions were provided, including the specific agent (typically aspirin 81 mg or 325 mg daily), the rationale for continuing therapy, and instructions not to discontinue without provider authorization.
- Peripheral arterial bypass procedures (aortobifemoral, femoral-popliteal, femoral-tibial) require discharge instructions that address graft surveillance and signs of limb-threatening ischemia. Patients must be instructed on the six Ps of acute limb ischemia: pain, pallor, paresthesia, pulselessness, poikilothermia (coldness), and paralysis. Any combination of these findings in the operated extremity warrants immediate evaluation and should be documented in discharge instructions as an indication for emergency care, not a next-day phone call. The SVS recommends duplex ultrasound surveillance of lower-extremity bypass grafts at intervals specified in SVS practice guidelines (typically at 1 month, 6 months, and annually thereafter for prosthetic grafts), and the discharge documentation must include the scheduled first surveillance appointment.
- Endovascular abdominal aortic aneurysm repair (EVAR) requires post-discharge surveillance imaging to detect endoleak, graft migration, or aneurysm sac expansion. CMS Medicare coverage policy requires CT angiography surveillance at 1 month and 12 months post-EVAR, with additional imaging if surveillance identifies complications. Discharge instructions must address the surveillance schedule explicitly, including the type of imaging required (CT angiography with contrast versus duplex ultrasound as an alternative for patients with contrast allergy or renal insufficiency), the anticipated frequency of ongoing surveillance, and the practice's process for ordering and reviewing surveillance imaging. Patients who do not understand the surveillance obligation may defer scheduled imaging, creating an undetected endoleak or device migration risk.
- Arteriovenous (AV) fistula and AV graft creation for hemodialysis access requires patient education on protecting the access site and monitoring for maturation. Discharge instructions must cover: keeping the access arm elevated for the first 24 to 48 hours after surgery to reduce swelling; how to check for a thrill (vibration) and bruit (sound) that indicate a patent access; signs of thrombosis (loss of thrill or bruit) that require immediate reporting; wound care for the surgical incision; activity restrictions including avoiding tight clothing, blood pressure cuffs, and venipuncture in the access arm; and the timeline for access maturation before first use. SVS clinical practice guidelines note that arteriovenous fistulas require a maturation period of at least 6 weeks before cannulation, and this timeline must be communicated to both the patient and the nephrology team in the discharge documentation.
Anticoagulation and Antiplatelet Therapy Documentation
- Vascular surgery patients are frequently discharged with anticoagulation or antiplatelet therapy, and medication instructions are among the highest-priority elements of the vascular surgery discharge document. Discharge medication instructions for anticoagulation must specify the agent by generic and brand name, the dose and frequency, the route of administration, the duration of therapy or the follow-up plan for ongoing management, and the monitoring required (for example, INR monitoring for warfarin or platelet count monitoring for patients on heparin products). For warfarin-anticoagulated patients, the discharge document must identify the anticoagulation management service or provider who will conduct INR monitoring and must specify the target INR range and the first anticipated monitoring date.
- Direct oral anticoagulants (DOACs) including apixaban (Eliquis), rivaroxaban (Xarelto), and dabigatran (Pradaxa) are prescribed after some vascular procedures and require specific patient education because laboratory monitoring is not routinely performed. Discharge instructions for DOAC therapy must address: the importance of not missing doses; what to do if a dose is missed (take the missed dose on the same day if remembered, do not double dose); drug interactions that increase bleeding risk, particularly NSAIDs and aspirin unless specifically prescribed; and signs of bleeding (unusual bruising, blood in urine or stool, prolonged bleeding from minor cuts) that warrant provider contact. Patients who stop anticoagulation due to bleeding concerns without provider guidance are at risk for thromboembolic events, and this risk must be explicitly addressed in the discharge communication.
- Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor (clopidogrel, ticagrelor, or prasugrel) is prescribed after some vascular procedures including carotid interventions and lower extremity endovascular procedures. Discharge documentation must address the specific agents, the duration of DAPT (which varies by procedure and individual patient risk), and the instruction not to discontinue either agent without explicit provider authorization. A patient who discontinues their P2Y12 inhibitor before the end of the prescribed therapy period for a planned dental procedure or elective surgery, without consulting the vascular surgery team, is at elevated risk for thrombotic complications. The discharge instruction must include a contact number for the vascular surgery practice so patients can address such questions before stopping antiplatelet therapy.
- Drug interactions relevant to anticoagulation and antiplatelet therapy must be addressed in vascular surgery discharge instructions. NSAIDs including ibuprofen, naproxen, and ketorolac increase bleeding risk in patients taking anticoagulants or antiplatelet agents and should be specifically named in the discharge instructions as agents to avoid unless directed by the prescribing provider. Proton pump inhibitor (PPI) prophylaxis is recommended by some professional societies for patients on DAPT to reduce gastrointestinal bleeding risk; if prescribed, the discharge instructions should specify the agent, dose, and duration. Patients who self-select OTC ibuprofen for post-operative pain management without awareness of the interaction with their antiplatelet or anticoagulation regimen create a preventable bleeding risk that can be mitigated through explicit medication instruction at discharge.
Wound Care, Activity Restrictions, and Surveillance Follow-Up Documentation
- Vascular surgery incisions require specific wound care instructions because the surgical sites (groin, popliteal fossa, neck) are in locations subject to movement, moisture, and contamination. Wound care instructions must specify: how to clean the incision (gentle soap and water versus no direct contact until the incision is sealed); dressing change technique and frequency; how to recognize signs of wound infection (increasing redness, warmth, swelling, purulent drainage, or fever); and the timeline for suture or staple removal. Groin incisions for femoral artery access are at elevated risk for wound complications due to the proximity of the inguinal lymphatics and the difficulty of maintaining a dry environment in that anatomical region. Patients with groin incisions should receive specific instructions on keeping the area dry, avoiding tight-fitting clothing that may trap moisture, and monitoring for lymphocele formation (a soft, fluctuant swelling without signs of infection) that requires provider evaluation.
- Access site care instructions for endovascular procedures performed through femoral, radial, or brachial artery access must address hemostasis monitoring in the first 24 to 48 hours after discharge. Patients discharged the same day as an endovascular procedure must be instructed to: keep the access extremity elevated and limit activity for the rest of the day; monitor the puncture site for hematoma expansion (a firm, enlarging bruise); apply direct manual pressure immediately if active bleeding occurs and call 911 if pressure does not control bleeding within 5 minutes; and avoid heavy lifting or strenuous activity with the access extremity for at least 48 to 72 hours. A pseudoaneurysm at the femoral access site may present as a pulsatile mass with a bruit and requires urgent imaging; discharge instructions for femoral access patients should specifically describe this finding as a reason for same-day provider contact.
- Activity restrictions after vascular surgery vary by procedure type and must be individualized in the discharge instructions. After open aortic surgery (aortobifemoral bypass, open AAA repair), patients typically require 6 to 8 weeks of restrictions on lifting more than 10 pounds and driving. After femoral-popliteal bypass, patients are typically restricted from prolonged sitting with the knee flexed for 2 to 4 weeks, as extreme knee flexion can kink a prosthetic graft. After carotid endarterectomy, patients are typically restricted from heavy lifting and strenuous neck movement for 2 to 4 weeks. These procedure-specific restrictions must be stated explicitly in the discharge document rather than in generic surgical restriction language, because patients may apply generic instructions inappropriately to a procedure with unique anatomical considerations.
- Surveillance follow-up scheduling must be confirmed and documented before the vascular surgery patient is discharged. The discharge record must include: the date and location of the first post-operative clinic appointment, the scheduled date of the first surveillance imaging study if applicable (duplex ultrasound or CT angiography depending on the procedure), the contact number for the vascular surgery practice for urgent questions, and the process for reaching an on-call vascular surgeon after hours. The SVS recommends that patients undergoing lower extremity revascularization have their first post-operative duplex surveillance completed within 30 days of the procedure. A discharge record that does not confirm a specific surveillance appointment, or that provides only a general instruction to follow up, leaves the surveillance schedule dependent on patient-initiated action and increases the risk of a missed surveillance imaging study.